Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Twenty One Capital, Inc.XXI · Entity 4168 | Chief Financial Officer | October 02, 2026 | October 02, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Twenty One Capital, Inc.
Report date October 02, 2026 · Filed October 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A common stockSEC Table I · non-derivative | Direct | 177,326 |
Reported balance
After 2026-10-02 transaction · row 1
1 source rowRow 1 · 2026-10-02 · Tax withholding · Disposed 4,394 · Balance 177,326 F1: Represents shares of Class A common stock withheld by the Issuer to satisfy tax withholding upon the vesting of RSUs. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of Class A common stock withheld by the Issuer to satisfy tax withholding upon the vesting of RSUs.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Kadmon Holdings, Inc.
Report date November 09, 2021 · Filed November 09, 2021
Section 16 reporting ended · disclosed 2021-11-09. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2021-11-09 transaction · row 1
1 source rowRow 1 · 2021-11-09 · Disposition to issuer · Disposed 24,909 · Balance 0 F1: Disposed pursuant to the acquisition by Sanofi of the entire issued share capital of Issuer on November 9, 2021 by means of a plan of merger (the "Merger"). |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.12 · Expires 2027-06-29 | Direct | 0 |
Reported balance
After 2021-11-09 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2021-11-09 · Disposition to issuer · Disposed 25,000 · Balance 0 F3: Represents the payment per share of Common Stock received in exchange for the cancellation of each Option. F2: In connection with the Merger, all unvested stock options ("Options") were accelerated to full vesting and cancelled in exchange for a payment equal to $9.50 with respect to each share of Common Stock subject to such Option |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.35 · Expires 2028-07-27 | Direct | 0 |
Reported balance
After 2021-11-09 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2021-11-09 · Disposition to issuer · Disposed 25,000 · Balance 0 F3: Represents the payment per share of Common Stock received in exchange for the cancellation of each Option. F2: In connection with the Merger, all unvested stock options ("Options") were accelerated to full vesting and cancelled in exchange for a payment equal to $9.50 with respect to each share of Common Stock subject to such Option |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.17 · Expires 2029-02-08 | Direct | 0 |
Reported balance
After 2021-11-09 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2021-11-09 · Disposition to issuer · Disposed 400,000 · Balance 0 F3: Represents the payment per share of Common Stock received in exchange for the cancellation of each Option. F2: In connection with the Merger, all unvested stock options ("Options") were accelerated to full vesting and cancelled in exchange for a payment equal to $9.50 with respect to each share of Common Stock subject to such Option |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.34 · Expires 2030-01-27 | Direct | 0 |
Reported balance
After 2021-11-09 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2021-11-09 · Disposition to issuer · Disposed 500,000 · Balance 0 F3: Represents the payment per share of Common Stock received in exchange for the cancellation of each Option. F2: In connection with the Merger, all unvested stock options ("Options") were accelerated to full vesting and cancelled in exchange for a payment equal to $9.50 with respect to each share of Common Stock subject to such Option |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.96 · Expires 2031-01-08 | Direct | 0 |
Reported balance
After 2021-11-09 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2021-11-09 · Disposition to issuer · Disposed 1,020,000 · Balance 0 F3: Represents the payment per share of Common Stock received in exchange for the cancellation of each Option. F2: In connection with the Merger, all unvested stock options ("Options") were accelerated to full vesting and cancelled in exchange for a payment equal to $9.50 with respect to each share of Common Stock subject to such Option |
Filing footnotes · ownership attribution and instrument terms
F1: Disposed pursuant to the acquisition by Sanofi of the entire issued share capital of Issuer on November 9, 2021 by means of a plan of merger (the "Merger").
F2: In connection with the Merger, all unvested stock options ("Options") were accelerated to full vesting and cancelled in exchange for a payment equal to $9.50 with respect to each share of Common Stock subject to such Option
F3: Represents the payment per share of Common Stock received in exchange for the cancellation of each Option.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 02, 2026 Filed Oct 2, 2026 21:30 UTC | Twenty One Capital, Inc. XXI · Entity 4168 | Tax withholdingClass A common stock | 4,394 | $6.77 | $29,747.38 |
DisclosureSEC source: 0001213900-26-106558 · ownership.xml · nonDerivative · entry 1 Meehan Steven · CIK 0001695617 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 177,326 F1 · shares: Represents shares of Class A common stock withheld by the Issuer to satisfy tax withholding upon the vesting of RSUs. Read SEC document |
| July 29, 2026 Filed Jul 30, 2026 22:56 UTC | Twenty One Capital, Inc. XXI · Entity 4168 | Tax withholdingClass A common stock | 4,271 | $4.35 | $18,578.85 |
DisclosureSEC source: 0001213900-26-083464 · ownership.xml · nonDerivative · entry 1 Meehan Steven · CIK 0001695617 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 181,720 F1 · shares: Represents shares of Class A common stock withheld by the Issuer to satisfy tax withholding upon the vesting of RSUs. Read SEC document |
| April 09, 2026 Filed Apr 13, 2026 20:15 UTC | Twenty One Capital, Inc. XXI · Entity 4168 | Tax withholdingClass A common stock | 18,232 | $6.64 | $121,060.48 |
DisclosureSEC source: 0001213900-26-042983 · ownership.xml · nonDerivative · entry 2 Meehan Steven · CIK 0001695617 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 185,991 F2 · shares: Represents shares of Class A common stock withheld by the Issuer to satisfy tax withholding upon the vesting of RSUs. Read SEC document |
| April 09, 2026 Filed Apr 13, 2026 20:15 UTC | Twenty One Capital, Inc. XXI · Entity 4168 | GrantClass A common stock | 204,223 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-042983 · ownership.xml · nonDerivative · entry 1 Meehan Steven · CIK 0001695617 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 204,223 F1 · shares: Represents a grant of restricted stock units ("RSUs"), which vest as follows: (a) 25% of the restricted stock units vested as of April 1, 2026, and (b) the remaining 75% of the RSUs will vest quarterly in equal tranches over the subsequent three years. Each RSU represents a contingent right to receive one share of Class A common stock. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 01:12 UTC | Twenty One Capital, Inc. XXI · Entity 4168 | GrantStock Option (Right to Buy) · Derivative | 796,951 | $0.00 Strike: $14.43 | $0.00 |
DisclosureSEC source: 0001213900-26-001443 · ownership.xml · derivative · entry 1 Meehan Steven · CIK 0001695617 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 796,951 Underlying: Class A common stock · 796,951 shares Expires 2036-01-02 F1 · derivative.exercise_date: The stock options vest as follows: (a) 25% of the stock options will vest on April 1, 2026, and (b) the remaining 75% of the stock options will vest quarterly in equal tranches over the subsequent three years. Read SEC document |
| November 09, 2021 Filed Nov 9, 2021 22:38 UTC | Kadmon Holdings, Inc. KDMN · Entity 133686 | Disposition to issuerStock Option (right to buy) · Derivative | 1,020,000 | $5.54 Strike: $3.96 | $5,650,800.00 |
DisclosureSEC source: 0001104659-21-136403 · tm2131118-5_4seq1.xml · derivative · entry 6 Meehan Steven · CIK 0001695617 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, par value $0.001 · 1,020,000 shares Expires 2031-01-08 F3 · price: Represents the payment per share of Common Stock received in exchange for the cancellation of each Option. F2 · derivative.exercise_date: In connection with the Merger, all unvested stock options ("Options") were accelerated to full vesting and cancelled in exchange for a payment equal to $9.50 with respect to each share of Common Stock subject to such Option Read SEC document |
| November 09, 2021 Filed Nov 9, 2021 22:38 UTC | Kadmon Holdings, Inc. KDMN · Entity 133686 | Disposition to issuerStock Option (right to buy) · Derivative | 500,000 | $5.16 Strike: $4.34 | $2,580,000.00 |
DisclosureSEC source: 0001104659-21-136403 · tm2131118-5_4seq1.xml · derivative · entry 5 Meehan Steven · CIK 0001695617 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, par value $0.001 · 500,000 shares Expires 2030-01-27 F3 · price: Represents the payment per share of Common Stock received in exchange for the cancellation of each Option. F2 · derivative.exercise_date: In connection with the Merger, all unvested stock options ("Options") were accelerated to full vesting and cancelled in exchange for a payment equal to $9.50 with respect to each share of Common Stock subject to such Option Read SEC document |
| November 09, 2021 Filed Nov 9, 2021 22:38 UTC | Kadmon Holdings, Inc. KDMN · Entity 133686 | Disposition to issuerStock Option (right to buy) · Derivative | 400,000 | $7.33 Strike: $2.17 | $2,932,000.00 |
DisclosureSEC source: 0001104659-21-136403 · tm2131118-5_4seq1.xml · derivative · entry 4 Meehan Steven · CIK 0001695617 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, par value $0.001 · 400,000 shares Expires 2029-02-08 F3 · price: Represents the payment per share of Common Stock received in exchange for the cancellation of each Option. F2 · derivative.exercise_date: In connection with the Merger, all unvested stock options ("Options") were accelerated to full vesting and cancelled in exchange for a payment equal to $9.50 with respect to each share of Common Stock subject to such Option Read SEC document |
| November 09, 2021 Filed Nov 9, 2021 22:38 UTC | Kadmon Holdings, Inc. KDMN · Entity 133686 | Disposition to issuerStock Option (right to buy) · Derivative | 25,000 | $6.15 Strike: $3.35 | $153,750.00 |
DisclosureSEC source: 0001104659-21-136403 · tm2131118-5_4seq1.xml · derivative · entry 3 Meehan Steven · CIK 0001695617 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, par value $0.001 · 25,000 shares Expires 2028-07-27 F3 · price: Represents the payment per share of Common Stock received in exchange for the cancellation of each Option. F2 · derivative.exercise_date: In connection with the Merger, all unvested stock options ("Options") were accelerated to full vesting and cancelled in exchange for a payment equal to $9.50 with respect to each share of Common Stock subject to such Option Read SEC document |
| November 09, 2021 Filed Nov 9, 2021 22:38 UTC | Kadmon Holdings, Inc. KDMN · Entity 133686 | Disposition to issuerStock Option (right to buy) · Derivative | 25,000 | $5.38 Strike: $4.12 | $134,500.00 |
DisclosureSEC source: 0001104659-21-136403 · tm2131118-5_4seq1.xml · derivative · entry 2 Meehan Steven · CIK 0001695617 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, par value $0.001 · 25,000 shares Expires 2027-06-29 F3 · price: Represents the payment per share of Common Stock received in exchange for the cancellation of each Option. F2 · derivative.exercise_date: In connection with the Merger, all unvested stock options ("Options") were accelerated to full vesting and cancelled in exchange for a payment equal to $9.50 with respect to each share of Common Stock subject to such Option Read SEC document |
| November 09, 2021 Filed Nov 9, 2021 22:38 UTC | Kadmon Holdings, Inc. KDMN · Entity 133686 | Disposition to issuerCommon Stock | 24,909 | $9.50 | $236,635.50 |
DisclosureSEC source: 0001104659-21-136403 · tm2131118-5_4seq1.xml · nonDerivative · entry 1 Meehan Steven · CIK 0001695617 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Disposed pursuant to the acquisition by Sanofi of the entire issued share capital of Issuer on November 9, 2021 by means of a plan of merger (the "Merger"). Read SEC document |
| January 08, 2021 Filed Jan 12, 2021 21:26 UTC | Kadmon Holdings, Inc. KDMN · Entity 133686 | GrantStock Option (right to buy) · Derivative | 1,020,000 | $0.00 Strike: $3.96 | $0.00 |
DisclosureSEC source: 0001593968-21-000119 · primary_01.xml · derivative · entry 1 Meehan Steven · CIK 0001695617 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,020,000 Underlying: Common stock, par value $0.001 · 1,020,000 shares Expires 2031-01-08 F1 · derivative.exercise_date: The option vests and becomes exercisable in three equal annual installments over 3 years from January 8, 2021, the date of grant. Read SEC document |
| January 27, 2020 Filed Jan 29, 2020 21:26 UTC | Kadmon Holdings, Inc. KDMN · Entity 133686 | GrantStock Option (right to buy) · Derivative | 500,000 | $0.00 Strike: $4.34 | $0.00 |
DisclosureSEC source: 0001593968-20-000231 · primary_01.xml · derivative · entry 1 Meehan Steven · CIK 0001695617 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500,000 Underlying: Common stock, par value $0.001 · 500,000 shares Expires 2030-01-27 F1 · derivative.exercise_date: The option vests and becomes exercisable in three equal annual installments over 3 years from January 27, 2020, the date of grant. Read SEC document |
| February 08, 2019 Filed Feb 11, 2019 21:20 UTC | Kadmon Holdings, Inc. KDMN · Entity 133686 | GrantOption (right to buy) · Derivative | 400,000 | $0.00 Strike: $2.17 | $0.00 |
DisclosureSEC source: 0001593968-19-000406 · primary_01.xml · derivative · entry 1 Meehan Steven · CIK 0001695617 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,000 Underlying: Common Stock, par value $0.001 · 400,000 shares Expires 2029-02-08 F1 · derivative.exercise_date: The option becomes vested and exercisable in three equal annual installments over 3 years from February 8, 2019, the date of grant. F2 · balance_after: Only represents derivative securities of this class. Read SEC document |
| July 27, 2018 Filed Jul 30, 2018 21:08 UTC | Kadmon Holdings, Inc. KDMN · Entity 133686 | GrantStock Option (right to buy) · Derivative | 25,000 | $3.35 Strike: $3.35 | $83,750.00 |
DisclosureSEC source: 0001593968-18-001077 · primary_01.xml · derivative · entry 1 Meehan Steven · CIK 0001695617 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock, par value $0.001 · 25,000 shares Expires 2028-07-27 F1 · derivative.exercise_date: The option becomes vested and exercisable on July 27, 2018. F2 · balance_after: Only represents derivative securities of this class. Read SEC document |
| June 29, 2017 Filed Jun 30, 2017 22:53 UTC | Kadmon Holdings, Inc. KDMN · Entity 133686 | GrantStock Option (right to buy) · Derivative | 25,000 | $4.12 Strike: $4.12 | $103,000.00 |
DisclosureSEC source: 0001593968-17-000847 · primary_01.xml · derivative · entry 1 Meehan Steven · CIK 0001695617 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock, par value $0.001 · 25,000 shares Expires 2027-06-29 F1 · derivative.exercise_date: The option becomes vested and exercisable on June 29, 2018. F2 · balance_after: Only represents derivative securities of this class. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.